Literature DB >> 16004841

Horton's disease: past and present.

Morris Levin1, Thomas N Ward.   

Abstract

Although the disease known as temporal arteritis, giant cell arteritis, and Horton's disease has been known since at least the 10th century, Hutchinson (1890) and Horton (1932) characterized the condition in the more recent medical literature. The diagnosis of this potentially serious illness can be surprisingly elusive, and treatment is fraught with some frustrating pitfalls. For the most part, careful evaluation of patients (usually elderly) with the typical presentation of head pain and constitutional signs yields prompt diagnosis. Treatment with corticosteroids, the standard since the mid-1950s, is usually very successful in relieving pain and tenderness and in preventing visual and other sequelae. This article discusses the evolution of medical understanding of the disease, pathophysiology, diagnosis, and modern treatment options.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16004841     DOI: 10.1007/s11916-005-0033-4

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  32 in total

Review 1.  Therapy of neurological disorders in systemic vasculitis.

Authors:  Ralf Gold; Adriano Fontana; Stephan Zierz
Journal:  Semin Neurol       Date:  2003-06       Impact factor: 3.420

2.  Temporal arteritis: diagnostic and therapeutic considerations.

Authors:  A F AbuRrahma; L Thaxton
Journal:  Am Surg       Date:  1996-06       Impact factor: 0.688

3.  Temporal or giant cell arteritis.

Authors:  S P Meadows
Journal:  Proc R Soc Med       Date:  1966-04

4.  Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis.

Authors:  Gideon Nesher; Yaakov Berkun; Michal Mates; Mario Baras; Alan Rubinow; Moshe Sonnenblick
Journal:  Arthritis Rheum       Date:  2004-04

Review 5.  Giant cell arteritis: strategies in diagnosis and treatment.

Authors:  Elisabeth Nordborg; Claes Nordborg
Journal:  Curr Opin Rheumatol       Date:  2004-01       Impact factor: 5.006

6.  Immediate and long-term outcome of upper extremity balloon angioplasty in giant cell arteritis.

Authors:  Beatrice R Amann-Vesti; Renate Koppensteiner; Lisa Rainoni; Thomas Pfamatter; Ernst Schneider
Journal:  J Endovasc Ther       Date:  2003-04       Impact factor: 3.487

7.  Pathological changes in temporal arteries removed from unselected cadavers.

Authors:  R W AINSWORTH; G A GRESHAM; G V BALMFORTH
Journal:  J Clin Pathol       Date:  1961-03       Impact factor: 3.411

8.  Methotrexate for corticosteroid-resistant polymyalgia rheumatica and giant cell arteritis.

Authors:  P L Krall; D J Mazanec; W S Wilke
Journal:  Cleve Clin J Med       Date:  1989-05       Impact factor: 2.321

9.  Percutaneous management of occlusive arterial disease associated with vasculitis: a single center experience.

Authors:  M Both; T Jahnke; E Reinhold-Keller; M Reuter; J Grimm; J Biederer; J Brossmann; W L Gross; M Heller; S Mueller-Huelsbeck
Journal:  Cardiovasc Intervent Radiol       Date:  2003-01-16       Impact factor: 2.740

Review 10.  Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy.

Authors:  Sohan Singh Hayreh; Bridget Zimmerman
Journal:  Ophthalmology       Date:  2003-06       Impact factor: 12.079

View more
  1 in total

1.  Horton's disease: still an important medical problem in elderly patients: a review and case report.

Authors:  Krzysztof Gomułka; Joanna Radzik-Zając; Urszula Zaleska-Dorobisz; Bernard Panaszek
Journal:  Postepy Dermatol Alergol       Date:  2017-10-31       Impact factor: 1.837

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.